Karuna Therapeutics, Inc.
NASDAQ:KRTX
329.83 (USD) • At close March 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0.654 | 5.278 | 0.081 | 5.278 | 0 | 36.964 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.447 | 0.458 | 0.469 | 0.327 | 0.305 | 0.29 | 0.269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.447 | -0.458 | -0.469 | 0.327 | 4.973 | -0.209 | 5.009 | 0 | 36.964 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.5 | 0.942 | -2.58 | 0.949 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 82.192 | 103.952 | 92.49 | 85.467 | 66.004 | 61.95 | 52.487 | 43.806 | 45.092 | 38.775 | 24.147 | 20.186 | 15.584 | 12.585 | 10.819 | 4.42 | 4.992 | 5.793 | 6.784 | 6.967 | 6.72 | 1.417 | 2.175 | 1.224 |
| General & Administrative Expenses
| 47.394 | 32.266 | 27.417 | 24.253 | 24.31 | 19.125 | 17.843 | 14.788 | 20.063 | 12.393 | 10.384 | 9.777 | 8.823 | 6.944 | 7.006 | 5.635 | 3.874 | 4.103 | 8.286 | 4.606 | 1.426 | 1.056 | 0.256 | 0.236 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 47.394 | 32.266 | 27.417 | 24.253 | 24.31 | 19.125 | 17.843 | 14.788 | 20.063 | 12.393 | 10.384 | 9.777 | 8.823 | 6.944 | 7.006 | 5.635 | 3.874 | 4.103 | 8.286 | 4.606 | 1.426 | 1.056 | 0.256 | 0.236 |
| Other Expenses
| 0.147 | 0.147 | 0.147 | 0.147 | 0.147 | 0.147 | 0.147 | 0.139 | 0.123 | 0.122 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 129.586 | 136.218 | 119.907 | 109.72 | 90.314 | 81.075 | 70.33 | 58.594 | 65.155 | 51.168 | 34.531 | 29.963 | 24.407 | 19.529 | 17.825 | 10.055 | 8.866 | 9.896 | 15.07 | 11.573 | 8.146 | 2.473 | 2.431 | 1.46 |
| Operating Income
| -129.586 | -136.218 | -119.907 | -109.066 | -85.036 | -80.994 | -65.052 | -58.594 | -28.191 | -51.168 | -34.531 | -29.963 | -24.407 | -19.529 | -17.825 | -10.055 | -8.866 | -9.896 | -15.07 | -11.573 | -8.146 | -2.473 | -2.431 | -1.46 |
| Operating Income Ratio
| 0 | 0 | 0 | -166.768 | -16.111 | -999.926 | -12.325 | 0 | -0.763 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 16.432 | 17.099 | 16.744 | 11.492 | 9.714 | 4.031 | 0.637 | 0.376 | 0.237 | 0.236 | 0.115 | -0.534 | 0.441 | 0.688 | 0.779 | 1.397 | 1.092 | 0.858 | -0.07 | -0.432 | -0.181 | -3.765 | 1.892 | -0.948 |
| Income Before Tax
| -113.154 | -119.119 | -103.163 | -97.574 | -75.322 | -76.963 | -64.415 | -58.218 | -27.954 | -50.932 | -34.416 | -30.497 | -23.966 | -18.841 | -17.046 | -8.658 | -7.774 | -9.038 | -15.14 | -12.005 | -8.327 | -6.238 | -0.539 | -2.408 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -149.196 | -14.271 | -950.16 | -12.204 | 0 | -0.756 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.67 | -17.41 | -17.066 | -11.492 | 0.89 | -7.915 | 0.528 | -0.613 | 0.006 | -0.114 | -0.106 | 0.534 | 0.043 | 0.688 | 0.779 | 1.397 | 1.071 | 0.858 | 0.452 | 0.412 | 0.191 | 1.132 | 0.392 | 0.868 |
| Net Income
| -113.824 | -119.119 | -103.163 | -86.082 | -76.212 | -69.048 | -64.943 | -57.605 | -27.96 | -50.932 | -34.416 | -30.497 | -24.009 | -18.841 | -17.046 | -8.658 | -7.774 | -9.038 | -15.14 | -12.005 | -8.327 | -6.238 | -0.539 | -2.408 |
| Net Income Ratio
| 0 | 0 | 0 | -131.624 | -14.44 | -852.444 | -12.304 | 0 | -0.756 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3.01 | -3.16 | -2.75 | -2.47 | -2.22 | -2.13 | -2.17 | -1.93 | -0.94 | -1.72 | -1.17 | -1.1 | -0.89 | -0.71 | -0.65 | -0.33 | -0.32 | -0.39 | -146.02 | -0.56 | -0.77 | -0.57 | -0.05 | -0.22 |
| EPS Diluted
| -3.01 | -3.16 | -2.75 | -2.47 | -2.22 | -2.13 | -2.17 | -1.93 | -0.94 | -1.72 | -1.17 | -1.1 | -0.89 | -0.71 | -0.65 | -0.33 | -0.32 | -0.39 | -146.02 | -0.56 | -0.77 | -0.57 | -0.05 | -0.22 |
| EBITDA
| -129.139 | -136.218 | -119.907 | -109.066 | -85.036 | -80.704 | -64.783 | -58.346 | -28.166 | -51.062 | -34.479 | -29.174 | -23.966 | -18.798 | -17.013 | -8.637 | -7.774 | -9.023 | -14.606 | -11.448 | -8.117 | -2.281 | -2.43 | -1.459 |
| EBITDA Ratio
| 0 | 0 | 0 | -166.768 | -16.111 | -996.346 | -12.274 | 0 | -0.762 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |